Pyrrolidin-2-one derivatives for use as DP1 receptor agonists

Details for Australian Patent Application No. 2005313380 (hide)

Owner Applied Research Systems ARS Holding N.V.

Inventors Araldi, Gian Luca

Agent Griffith Hack

Pub. Number AU-A-2005313380

PCT Pub. Number WO2006/061366

Priority 60/633,612 06.12.04 US

Filing date 5 December 2005

Wipo publication date 15 June 2006

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/061366 Priority application(s): WO2006/061366

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313386-Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites

2005313370-Valve for a surgical or medical instrument